AF
XBIT icon

Amalgamated Financial’s XBiotech XBIT Stock Holding History

Amalgamated Financial’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$16K Buy
+1,842
New +$18.5K ﹤0.01% 2803

Other funds holding XBIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Amalgamated Financial's XBIT Position: Q1 2022 in Review

Amalgamated Financial opened a new position in XBiotech (XBIT) in Q1 2022: 1,842 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #2803 among its holdings.

64 funds tracked by Wall St. Rank hold XBIT as of Q1 2022.

  • Amalgamated Financial held 1,842 shares of XBiotech worth $16K as of Q1 2022.
  • XBiotech was a new Amalgamated Financial position in Q1 2022.
  • XBiotech made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2803 holding.
  • 64 funds tracked by Wall St. Rank held XBiotech as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.